U.K. Looks at Expanding Tax Breaks for Investors in Startups
(Bloomberg) --
The U.K. government is considering policy changes to a popular program that provides preferential tax treatment for early-stage investments into tech companies, which could make it easier for companies to raise larger rounds of funding.
Talks among regulators about potentially expanding the Enterprise Investment Scheme and the Seed Enterprise Investment Scheme are in preliminary stages, according to people familiar with the matter, who asked for anonymity because the discussions are private.
A U.K. Treasury spokesperson said the government keeps all tax relief policies under review in order to ensure they meet policy objectives in a fair and effective way.
Both the EIS and SEIS incentivize individual investors to back new companies by offering significant tax relief.
Under the SEIS today, for instance, a company can raise as much as 150,000 pounds ($188,000) from individual investors, who would then be able to receive a reduction on their income tax liability with favorable capital gains treatment. But some in the startup industry have advocated for a cap of 250,000 pounds, allowing companies to more easily raise early funds.
The U.K.'s departure from the European Union and accompanying restrictions on state aid allows for reforms such as this, the people said; one added that it's more likely significant changes will be made to the SEIS rather than the EIS.
Since the EIS was launched in 1994, nearly 33,000 companies have netted a total of about 24 billion pounds in funds, U.K. government data show, and from SEIS's start in 2012 to 2013, about 14,000 companies have received about 1.4 billion pounds.
In a February report from data platform Beauhurst and venture firm SFC Capital, it was argued that changes to the SEIS were needed to increase the number of early U.K. venture investments.
“SEIS, as well as EIS, the tested and proven tools of investing in innovation, have to be reinvented, improved, and reinforced before it is too late,” the report's authors concluded.
©2022 Bloomberg L.P.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.